drugset / Trial / NCT01895894

Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome

NCT01895894

RandomizedParallel-groupOpen-labelTreatment

Summary

Idiopathic nephrotic syndrome is generally responsive to steroid therapy, but some patients need other immunosuppressants to reduce steroid dependency. The long-term use should be restricted due to adverse effects of cyclosporine, such as hypertension and nephrotoxicity. Mycophenolate mofetil for steroid-dependent nephrotic syndrome has been reported to have similar efficacy and fewer undesirable effects to other drugs in mainly observational studies. To determine the efficacy of mycophenolate mofetil in the management of steroid-dependent nephrotic syndrome, the investigators designed this prospective randomized controlled study.

Timeline

Start
2013-09
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Mofetil Small molecule 20 mg/kg Oral
Subject Mycophenolate Mofetil Small molecule 30 mg/kg Oral

Indications